|183.40||+0.3400||+0.19%||Vol 743.30K||1Y Perf 7.06%|
|Sep 18th, 2020 16:00 DELAYED|
|- -%||- -%|
|Target Price||215.69||Analyst Rating||Strong Buy 1.32|
|Potential %||17.61||Finscreener Ranking||★★ 46.51|
|Insiders Trans % 3/6/12 mo.||-100/-100/-85||Value Ranking||★ 42.47|
|Insiders Value % 3/6/12 mo.||-100/-100/-99||Growth Ranking||★★+ 48.66|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-99||Income Ranking||— -|
|Market Cap||17.86B||Earnings Rating||Strong Buy|
|Price Range Ratio 52W %||78.53||Earnings Date||22nd Oct 2020|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||22nd Oct 2020|
|Estimated EPS Next Report||4.76|
|EPS Growth Next 5 Years %||8.60|
|Avg. Weekly Volume||578.63K|
|Avg. Monthly Volume||864.08K|
|Avg. Quarterly Volume||823.73K|
Laboratory Corporation of America Holdings (NYSE: LH) stock closed at 183.4 per share at the end of the most recent trading day (a 0.19% change compared to the prior day closing price) with a volume of 775.64K shares and market capitalization of 17.86B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 61000 people. Laboratory Corporation of America Holdings CEO is Adam H. Schechter.
The one-year performance of Laboratory Corporation of America Holdings stock is 7.06%, while year-to-date (YTD) performance is 8.41%. LH stock has a five-year performance of 53.6%. Its 52-week range is between 98.02 and 206.74, which gives LH stock a 52-week price range ratio of 78.53%
Laboratory Corporation of America Holdings currently has a PE ratio of 49.60, a price-to-book (PB) ratio of 2.40, a price-to-sale (PS) ratio of 1.55, a price to cashflow ratio of 11.10, a PEG ratio of 2.32, a ROA of 2.05%, a ROC of 3.45% and a ROE of 5.03%. The company’s profit margin is 3.05%, its EBITDA margin is 12.50%, and its revenue ttm is $11.47 Billion , which makes it $117.81 revenue per share.
Of the last four earnings reports from Laboratory Corporation of America Holdings, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $4.76 for the next earnings report. Laboratory Corporation of America Holdings’s next earnings report date is 22nd Oct 2020.
The consensus rating of Wall Street analysts for Laboratory Corporation of America Holdings is Strong Buy (1.32), with a target price of $215.69, which is +17.61% compared to the current price. The earnings rating for Laboratory Corporation of America Holdings stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Laboratory Corporation of America Holdings has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Laboratory Corporation of America Holdings has a Buy technical analysis rating based on Technical Indicators (ADX : 25.23, ATR14 : 4.80, CCI20 : 81.84, Chaikin Money Flow : 0.16, MACD : -0.20, Money Flow Index : 55.25, ROC : 3.66, RSI : 52.94, STOCH (14,3) : 69.31, STOCH RSI : 0.28, UO : 55.90, Williams %R : -30.69), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Laboratory Corporation of America Holdings in the last 12-months were: Adam H. Schechter (Option Excercise at a value of $0), Brian J. Caveney (Option Excercise at a value of $0), D. Gary Gilliland (Option Excercise at a value of $0), David P. King (Option Excercise at a value of $0), David P. King (Sold 91 604 shares of value $14 982 432 ), Garheng Kong (Option Excercise at a value of $0), Glenn A. Eisenberg (Option Excercise at a value of $0), Jean-Luc Belingard (Option Excercise at a value of $239 289), Jean-Luc Belingard (Sold 26 479 shares of value $5 024 750 ), Judith C. Seltz (Buy at a value of $99 360), Kerrii B. Anderson (Option Excercise at a value of $256 074), Kerrii B. Anderson (Sold 2 600 shares of value $446 810 ), Lance V. Berberian (Option Excercise at a value of $0), Mark Schroeder (Option Excercise at a value of $0), Mark Schroeder (Sold 296 shares of value $55 091 ), Paul Kirchgraber (Option Excercise at a value of $0), Peter J. Wilkinson (Option Excercise at a value of $0), Peter J. Wilkinson (Sold 297 shares of value $56 326 ), Peter M. Neupert (Option Excercise at a value of $0), Richelle P. Parham (Option Excercise at a value of $0), Robert Sanders Williams (Option Excercise at a value of $128 037), Robert Sanders Williams (Sold 2 527 shares of value $456 333 ), Sandra D. van der Vaart (Option Excercise at a value of $0), Sandra D. van der Vaart (Sold 2 424 shares of value $414 529 )
Copyright (c) 2020. All rights reserved. Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.com, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.